OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex molecules. Improving these processes involves adjusting various variables, including cell line engineering, media composition, and bioreactor settings. A key goal is to amplify antibody production while lowering production costs a